Excessive Ca2+-dependent ER-mitochondrial contact stabilization by EFHD1 drives liver injury
David EberhardtiD, Emma C. RekateiD, Yasmin B Masini, Hannah E. Duron, David M. Mollinedo, Adrian M VelardeiD, DEVORAH STUCKI, Tara R. PriceiD, Sandra H. J. LeeiD, Enrique BalderasiD, Neeraj K RaiiD, Ashley R. BrattiD, Anthony M. BalynasiD, Chris StubbeniD, Ryan D. BiaiD, Sudipa MaityiD, Nicolas G. HarteliD, Xue Yin, Andrea C. CorbiniD, Anshu KumariiD, Dung M. Nguyen, Daisuke ShimuraiD, Vu D Nguyen, Vishaka Vinod, Kamrul Hasan Chowdhury, , Dipayan ChaudhuriiD
Abstract
Metabolic-associated steatohepatitis (MASH) involves hepatocyte damage that cannot be explained solely by lipid accumulation. Here, to discover injury-specific pathways, we focused on a gene of uncertain function, EF-Hand Domain Family Member D1 (EFHD1), identified in human genome-wide association studies of liver injury but not liver fat. We show that EFHD1, a Ca2+-dependent actin crosslinker, stabilizes endoplasmic reticulum-mitochondria contact sites (ERMCS), detecting spatiotemporal coincidence of inter-organellar proximity and ER Ca2+ release. During MASH, EFHD1 upregulation drives pathological mitochondrial fragmentation via excessive contact persistence. This structural failure promotes mitochondrial double-stranded RNA escape and activation of a maladaptive antiviral PKR-dependent stress response, a causal relationship also supported by Mendelian randomization in humans. Consequently, inhibiting EFHD1 in human and mouse models blunts hepatocyte damage. These findings identify EFHD1 as a Ca2+-dependent ERMCS stabilizer, reveal a hepatocyte-intrinsic injury pathway, and suggest EFHD1 inhibition as a therapeutic strategy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Diet-induced MASH liver fibrosis promoted by EphB2 can be targeted by small molecule tetramerization inhibitors
Masaaki Yoshigi, Séverin Donald Kamdem, … Patrice Nsangou Mimche·bioRxiv·Nov 19, 2025
- ARID5A Is a PERK-Dependent Effector of the Endoplasmic Reticulum Stress Response That Protects Against Steatohepatitis
Takahito Nishihara, Jasmin Weninger, … Harmeet Malhi·bioRxiv·Oct 16, 2026
- Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice
S. Baechler, LK Saha, … Yves G. Pommier·bioRxiv·Sep 5, 2024
- EFHD1 ablation reduces cardiac mitoflash activation and protects cardiomyocytes from ischemia.
D. R. Eberhardt, S. H. Lee, … D. Chaudhuri·bioRxiv·Oct 18, 2021
- Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
Marisa J. Brothwell, Guoshen Cao, … Katsuhiko Funai·eLifePeer-reviewed·Sep 2, 2026
- The effects of denifanstat on hepatitis E virus replication and triggered inflammatory response
Jiahua Zhou, Maikel Petrus Peppelenbosch, … Ibrahim Ayada·bioRxiv·Oct 16, 2025